Clozapine therapy was successfully continued alongside anticoagulation in a patient with recurrent pulmonary embolism, emphasizing the need for personalized treatment strategies.
Can clozapine therapy be continued with concurrent anticoagulation in patients who develop clozapine-associated pulmonary embolism?
This case demonstrates that clozapine therapy can be successfully continued with concurrent anticoagulation in patients who develop clozapine-associated pulmonary embolism.
Absolute Event Rate: 0% vs 0%
Clozapine, a gold standard for treatment‐resistant schizophrenia, is associated with a range of adverse effects, including the rare but serious risk of pulmonary embolism (PE). The management of such complications, particularly in the absence of clear guidelines for preventive anticoagulation, poses significant challenges. We present a case of a male (in his late 30s) with schizophrenia who developed recurrent thromboembolic events during clozapine therapy. Despite the occurrence of a second PE, clozapine therapy was continued successfully with concurrent anticoagulation. This case highlights the need for individualized treatment strategies and underscores the critical gap in evidence regarding preventive anticoagulation in patients with clozapine.
Jahangir等人（周四）报告了另一个病例。克洛扎平治疗在一名复发性肺栓塞患者中成功持续，同时进行抗凝治疗，强调了个性化治疗策略的必要性。